Loading...
13 Japan Generic Drugs Reports
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Ferring Pharmaceuticals, Otsuka Holdings Co., Astellas Pharma, Kyowa Kirin Co., Teva Pharmaceutical Industries
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Teva Pharmaceutical Industries, Viatris Inc. (Mylan-Upjohn), Sandoz Group AG, Sun Pharmaceuticals Industries, Dr. Reddy’s Laboratories Ltd.
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Fresenius, Pfizer, Viatris, Hikma Pharmaceuticals, Teva Pharmaceutical Industries
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Amarin Corporation plc, GlaxoSmithKline, Teva Pharmaceutical Industries, Hikma Pharmaceuticals, AstraZeneca
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Takeda Pharmaceuticals, AstraZeneca, Pfizer, Dr. Reddy’s Laboratories, GlaxoSmithKline
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: 3M, Molnlycke Health Care, Convatec, Smiths Group, Medline Industries
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: AstraZeneca, Bayer, Eli Lilly and Company, Johnson & Johnson, Abbvie
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Novartis, Astellas Pharma, Aurinia Pharmaceuticals Inc., Novaliq, Otsuka Pharmaceuticals
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Lupin, Viatris Inc.(Mylan Pharmaceuticals Inc.), Teva Pharmaceutical Industries, Zydus Lifesciences
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Pfizer, GlaxoSmithKline, Abbott Laboratories, Boston Scientific, Medtronic
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Pfizer, Teva Pharmaceutical Industries, Sun Pharmaceuticals Industries, Cipla, Novartis
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Fresenius, Novartis, Pfizer, Teva Pharmaceutical Industries, Hikma Pharmaceuticals
Country Covered: Japan
Study Period: 2019 - 2030
Major Players: Akorn, Cipla, Novartis, Teva Pharmaceutical Industries, Apotex